Professor Wong is a senior consultant in the Glaucoma Service at the Singapore National Eye Centre, and the current Vice Chair in Faculty and Professional Development for Ophthalmology at Duke NUS. She is also the Director of Clinical Translational Research and co-Head of the Ocular Therapeutics and Drug Delivery Group at the Singapore Eye Research Institute. Professor Wong has a specialist interest in ocular scarring and post glaucoma surgery management. She leads an inter-disciplinary research programme on translational and clinical research on developing new therapeutics as well as drug repurposing and sustained drug delivery systems aimed at improving patient adherence. Her research has improved the understanding of the burden and risk factors that affect the surgical outcomes of glaucoma surgery. She has established a validated animal model to interrogate the post surgical wound healing response as has published a roadmap for new therapeutic drug development from the lab to clinical. Professor Wong developed 2 sustained drug delivery therapies, reaching Ph2 clinical trials for the medical treatment of glaucoma and cataract surgery. She holds 10 patents to her name and is a co-founder of 3 spin off biotech companies generated from her research. Professor Wong is a scientific thought leader in the field of wound healing in glaucoma surgery and ocular drug delivery, having published widely in these areas. Professor Wong has received national and international awards for h